TRIOMICS

Welcome to the Brand page for “TRIOMICS”, which is offered here for Multimeric, particularly trimeric or hexameric pharmaceutical substances and preparations for the treatment of cancer, inflammatory bowel disease, and infectious diseases; therapeutic and diagnostic proteins and polypeptides for clinical or medical use; protein, antibody, and polypeptide conjugates for clinical or medical laboratory use; diagnostic and analytical preparations, receptor targeted conjugates,fusion proteins, cell lines producing proteins, radioactive and detectably labeled preparations and substances, and immunogenic and antigenic proteins for clinical or medical laboratory use;medical and veterinary services;biotechnology services, the development of new products and technologies for others in the field of biotechnology, scientific research and development, contract biochemical research services for others, licensing of intellectual property; and medical diagnostic research services;.

Its status is currently believed to be active. Its class is unavailable. “TRIOMICS” is believed to be currently owned by “KS Biomedix Holdings plc”.